🇺🇸 FDA
Patent

US 8969293

Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

granted A61KA61K31/155A61K38/26

Quick answer

US patent 8969293 (Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device) held by Rani Therapeutics, LLC expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rani Therapeutics, LLC
Grant date
Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/155, A61K38/26, A61K38/28, A61K45/06